Coronavirus vaccine: Moderna will have 100 million vaccine doses ready by early 2021 – United States and Canada – Switzerland

Moderna plans to have between 100 and 125 million doses of your covid-19 vaccine in the first quarter of 2021, the vast majority of which will go to the US, the US biotech company announced in a statement Thursday.

(Read also: How are vaccination plans going in Latin America?).

Between 85 and 100 million of these doses will be reserved for the United States and between 15 and 25 million to the rest of the world, the lab said. He also reaffirmed that 20 million doses will be available in the North American country by the end of the year.

Moderna has been preparing the supply chain with the Donald Trump administration for months now to make sure it can roll out as soon as the Drug Administration (FDA) approves it.

(Of your interest: They confirm that these drugs do not help patients with
COVID-19).

For all countries outside the United States, production will take place in Switzerland, at the factories of the Lonza group.

US officials said so they plan to distribute a total of 40 million doses by the end of the year in the country, including those produced by the German-American alliance Pfizer / BioNTech. About 20 million people would be vaccinated by the end of 2020, as the product is given in two doses.

(Keep reading: ‘Government must warn citizens of the potential risks of the vaccine’).

Moderna has applied for clearance from the FDA and the agency’s advisory board, which is reviewing the full clinical trial data, will meet on December 17. Permission for distribution of the vaccine is expected shortly after. The FDA’s meeting to review the Pfizer / BioNtech vaccine, which was approved Wednesday in the UK, will take place on 10 December.

AFP